Search

Your selection

None

Filter by content type

Filter by content year

News

Vaxart Publishes Positive Data for its Oral Bivalent Norovirus Candidate in Lactating Women and Their Infants

News

Dynavax Enters Exclusive License Agreement for Vaxart’s Novel Oral COVID-19 Vaccine Program

November 5, 2025 - … Vaxart . Actual results may differ materially from those set forth in this press release due to the risks and … Vaxart . Actual results may differ materially from those set forth in this press release due to the risks and … Vaxart . Actual results may differ materially from those set forth in this press release due to the risks and …
News

Vaxart Appoints W. Mark Watson as Lead Independent Director

September 17, 2025 - … votes from its stockholders with respect to the proposal set forth in the Proxy Statement. Vaxart encourages all … votes from its stockholders with respect to the proposal set forth in the Proxy Statement. Vaxart encourages all … votes from its stockholders with respect to the proposal set forth in the Proxy Statement. Vaxart encourages all …
News

Vaxart Announces Adjournment of Special Meeting of Stockholders

September 8, 2025 - … votes from its stockholders with respect to all proposals set forth in the Proxy Statement. Proxies previously … votes from its stockholders with respect to all proposals set forth in the Proxy Statement. Proxies previously … votes from its stockholders with respect to all proposals set forth in the Proxy Statement. Proxies previously …
News

Vaxart Announces Trading on OTCQX Best Market

July 8, 2025 - … before a Nasdaq Hearings Panel pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series. Pursuant to … before a Nasdaq Hearings Panel pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series. Pursuant to … before a Nasdaq Hearings Panel pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series. Pursuant to …
News

Vaxart Announces Adjournment of Annual Meeting of Stockholders

June 2, 2025 - … votes from its stockholders with respect to all proposals set forth in the Proxy Statement. Proxies previously … votes from its stockholders with respect to all proposals set forth in the Proxy Statement. Proxies previously … votes from its stockholders with respect to all proposals set forth in the Proxy Statement. Proxies previously …
News

Vaxart Announces Adjournment of Annual Meeting of Stockholders

May 21, 2025 - … votes from its stockholders with respect to all proposals set forth in the Proxy Statement. Proxies previously … votes from its stockholders with respect to all proposals set forth in the Proxy Statement. Proxies previously … votes from its stockholders with respect to all proposals set forth in the Proxy Statement. Proxies previously …
News

Vaxart Publishes Positive, Complete Data from a Phase 2b Challenge Study of its First-Generation Oral Pill Norovirus Vaccine Candidate in Science Translational Medicine

May 14, 2025 - … the quantity and duration of norovirus shedding, and a set of immunogenicity parameters also were quantified. The … the elderly: The challenge of immune changes with aging. Semin Immunol   40 , 83-94 (2018). A. Pera, C. Campos , N. … the quantity and duration of norovirus shedding, and a set of immunogenicity parameters also were quantified. The …
News

Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults

March 5, 2025 - … the elderly: The challenge of immune changes with aging. Semin Immunol   40 , 83-94 (2018). 2. A. Pera, C. Campos , N. … the elderly: The challenge of immune changes with aging. Semin Immunol   40 , 83-94 (2018). 2. A. Pera, C. Campos , N. … the elderly: The challenge of immune changes with aging. Semin Immunol   40 , 83-94 (2018). 2. A. Pera, C. Campos , N. …
News

Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet Need

Scroll to Top